Literature DB >> 6628390

The function of N alpha-acetylation of the eye-lens crystallins.

H P Driessen, F C Ramaekers, W T Vree Egberts, H J Dodemont, W W de Jong, G I Tesser, H Bloemendal.   

Abstract

The putative protective role of the N alpha-acetyl group of proteins has been investigated. Synthetic, non-acetylated N-terminal tetrapeptides of the alpha A2- and gamma II-crystallin chains are good substrates for leucine aminopeptidase, while the acetylated ones are completely resistant. In the native, non-acetylated, gamma-crystallin the N terminus is not degraded by leucine aminopeptidase. Newly synthesized alpha A2-crystallin, in which the normally occurring N-terminal acetylation has been prevented during cell-free translation, is virtually resistant against degradation by leucine aminopeptidase. Only at extreme enzyme-substrate ratios the N-terminal methionine is removed. Although the N alpha-acetyl group by its very nature protects against this exopeptidase, we conclude that the group is not essential for this purpose in the native crystallins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628390     DOI: 10.1111/j.1432-1033.1983.tb07756.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Acetylation of αA-crystallin in the human lens: effects on structure and chaperone function.

Authors:  Ram H Nagaraj; Rooban B Nahomi; Shilpa Shanthakumar; Mikhail Linetsky; Smitha Padmanabha; Nagarekha Pasupuleti; Benlian Wang; Puttur Santhoshkumar; Alok Kumar Panda; Ashis Biswas
Journal:  Biochim Biophys Acta       Date:  2011-11-18

2.  Identification of crystallin modifications in the human lens cortex and nucleus using laser capture microdissection and CyDye labeling.

Authors:  C O Asomugha; R Gupta; O P Srivastava
Journal:  Mol Vis       Date:  2010-03-23       Impact factor: 2.367

3.  Cataract-specific posttranslational modifications and changes in the composition of urea-soluble protein fraction from the rat lens.

Authors:  Lyudmila V Yanshole; Ivan V Cherepanov; Olga A Snytnikova; Vadim V Yanshole; Renad Z Sagdeev; Yuri P Tsentalovich
Journal:  Mol Vis       Date:  2013-11-07       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.